U.S. Stock SEC Cash-Flow Directory / Healthcare
VNDAAvoid
Vanda Pharmaceuticals Inc. · Pharmaceutical Preparations
Core Operations Burning Cash in Latest SEC Filing
Cash runway question: operations used $50.2M of cash before $221K in capital spending — ask how long existing liquidity (1.54x current ratio) lasts without issuing new shares or debt.
- Why did VNDA's capital spending push official SEC Free Cash Flow negative (-$50.4M), and when will cash generation turn positive again?
- What downside exit rule protects my portfolio if VNDA's current breakdown continues?
- Are there stronger Healthcare companies generating positive SEC Free Cash Flow with healthier trend support right now?
Official U.S. SEC EDGAR Filing Snapshot (VNDA)
Period Ended 2026-03-31 · Filed 2026-05-10See All 36 Healthcare Stocks Rated Accumulate Right Now
Every TFE Accumulate stock requires verified positive SEC Free Cash Flow, constructive multi-episode trend durability, and S&P 500 relative strength. Unlock the full 254-stock Accumulate roster, full 2,400+ stock Screener, and personal Watchlist.
Research Disclosure: Standardized impersonal model publication for research use only — not personalized investment advice and not a brokerage site. Verify all filings and live quotes independently before making investment decisions.